A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.
about
A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A double-blind, placebo-contro ...... n as a treatment for vitiligo.
@en
A double-blind, placebo-contro ...... n as a treatment for vitiligo.
@nl
type
label
A double-blind, placebo-contro ...... n as a treatment for vitiligo.
@en
A double-blind, placebo-contro ...... n as a treatment for vitiligo.
@nl
prefLabel
A double-blind, placebo-contro ...... n as a treatment for vitiligo.
@en
A double-blind, placebo-contro ...... n as a treatment for vitiligo.
@nl
P2093
P2860
P1476
A double-blind, placebo-contro ...... n as a treatment for vitiligo.
@en
P2093
Andrea Pearson
Bruce Barton
Celia Hartigan
Jillian M Richmond
John E Harris
Maryanne Makredes Senna
Michelle Kelley
Sandhya Chowdary
Shinya Amano
Stefan G Vanderweil
P2860
P304
150-151.e3
P356
10.1016/J.JAAD.2016.06.015
P407
P577
2017-01-01T00:00:00Z